JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199726

Anti-ATM antibody [EPR17059]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

2

(1 Review)

|

(26 Publications)

Rabbit Recombinant Monoclonal ATM antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 26 publications.

View Alternative Names

Serine-protein kinase ATM, Ataxia telangiectasia mutated, A-T mutated, ATM

8 Images
Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
  • IP

Supplier Data

Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)

ATM was immunoprecipitated from 1mg of HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : HEK-293 whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in HEK-293 whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in HEK-293 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)

Predicted band size: 351 kDa

false

Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
  • IP

Supplier Data

Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)

ATM was immunoprecipitated from 1mg of SH-SY5Y (Human neuroblastoma from bone marrow cells) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/500 dilution (Panel A) or ab32420 at 1/500 dilution (Panel B). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : SH-SY5Y whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in SH-SY5Y whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in SH-SY5Y whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds (Panel A and B).

All lanes:

Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)

Predicted band size: 351 kDa

false

Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)
  • IP

Supplier Data

Immunoprecipitation - Anti-ATM antibody [EPR17059] (AB199726)

ATM was immunoprecipitated from 1mg of HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate with ab199726 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab199726 at 1/500 dilution (Panel A) or ab32420 at 1/500 dilution (Panel B). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : HEK-293 whole cell lysate 10ug (Input). Lane 2 : ab199726 IP in HEK-293 whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199726 in HEK-293 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds (Panel A and B).

All lanes:

Immunoprecipitation - Anti-ATM antibody [EPR17059] (ab199726)

Predicted band size: 351 kDa

false

Western blot - Anti-ATM antibody [EPR17059] (AB199726)
  • WB

Supplier Data

Western blot - Anti-ATM antibody [EPR17059] (AB199726)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution

Lane 1:

Rat testis lysate at 10 µg

Lane 2:

Mouse testis lysate at 10 µg

Lane 3:

293 (Human epithelial cells from embryonic kidney) whole cell lysate at 10 µg

Lane 4:

SH-SY5Y (Human neuroblastoma from bone marrow cells) whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 351 kDa

Observed band size: 350 kDa

false

Exposure time: 20s

Western blot - Anti-ATM antibody [EPR17059] (AB199726)
  • WB

Lab

Western blot - Anti-ATM antibody [EPR17059] (AB199726)

False colour image of Western blot : Anti-ATM antibody [EPR17059] staining at 1/2000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab199726 was shown to bind specifically to ATM. A band was observed at 350 kDa in wild-type A549 cell lysates with no signal observed at this size in ATM knockout cell line ab276095 (knockout cell lysate ab283834). To generate this image, wild-type and ATM knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

ATM knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human ATM knockout A549 cell line (<a href='/en-us/products/cell-lines/human-atm-knockout-a549-cell-line-ab276095'>ab276095</a>)

Lane 3:

HEK-293 cell lysate at 20 µg

Lane 4:

U-2 OS cell lysate at 20 µg

Predicted band size: 351 kDa

Observed band size: 350 kDa

false

Western blot - Anti-ATM antibody [EPR17059] (AB199726)
  • WB

Supplier Data

Western blot - Anti-ATM antibody [EPR17059] (AB199726)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/5000 dilution

All lanes:

293 (Human epithelial cells from embryonic kidney) whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 351 kDa

Observed band size: 350 kDa

false

Exposure time: 3min

Western blot - Anti-ATM antibody [EPR17059] (AB199726)
  • WB

Supplier Data

Western blot - Anti-ATM antibody [EPR17059] (AB199726)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ATM antibody [EPR17059] (ab199726) at 1/2000 dilution

Lane 1:

Rat testis lysate at 10 µg

Lane 2:

Mouse testis lysate at 10 µg

Lane 3:

Mouse spleen lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 351 kDa

Observed band size: 350 kDa

false

Exposure time: 3min

Western blot - Anti-ATM antibody [EPR17059] (AB199726)
  • WB

CiteAb

Western blot - Anti-ATM antibody [EPR17059] (AB199726)

ATM western blot using anti-ATM antibody [EPR17059] ab199726. Publication image and figure legend from Zhao, X., Guo, X., et al., 2018, Cell Death Dis, PubMed 29352124.

ab199726 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab199726 please see the product overview.

HBX specifically inhibits CHK2 phosphorylationa, b Western blot for γH2AX in control and HBX-expressing SUDHL-4 a, and DB b, cells with or without MTX treatment (4 ng/ml) for 48 h. c, d Western blot for DDR proteins (P-CHK2/CHK2/ATM and P-CHK1/CHK1) in control and HBX-expressing SUDHL-4 c, and DB d, cells with or without MTX treatment (4 ng/ml) for 48 h. e, f The mRNA levels of DDR proteins (ATM, CHK2, and CHK1) were largely unchanged in control and HBX-expressing SUDHL-4 e, and DB f, cells with or without MTX treatment. g,h The expression of the P-CHK2 downstream genes P53 and P21 in control and HBX-expressing SUDHL-4 g, and DB h, cells with or without MTX treatment. The results are shown as the mean ± SEM from triplicate experiments. GAPDH was used as a loading control

false

  • Carrier free

    Anti-ATM antibody [EPR17059] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR17059

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/100", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ATM also known as Ataxia Telangiectasia Mutated is a protein kinase with a molecular weight of approximately 370 kDa. ATM protein primarily resides in the cell nucleus and functions as a critical regulator of the cell cycle. It plays a significant role in the detection of DNA damage and initiation of repair processes. As part of its mechanical functions ATM phosphorylates serine and threonine residues on various substrates most notably in response to double-strand breaks in DNA. This activity is important for maintaining genomic stability.
Biological function summary

ATM acts as a coordinator in cellular response to DNA damage highly interacting with multiple components of the DNA repair machinery. It forms a complex with proteins like NBS1 and MRN complex facilitating repair by recruiting and activating other proteins involved in homologous recombination and non-homologous end joining pathways. ATM also modulates p53 activity a primary response factor in cellular stress management linking ATM to control of cell cycle arrest and apoptosis. This positions ATM as an integral part of maintaining cellular integrity in face of genomic insult.

Pathways

ATM integrates neatly within the DNA damage response and cell cycle control pathways. ATM's operative relationship with the MRN complex and its role in the PI3K-related protein kinase family helps initiate appropriate repair processes upon DNA damage detection. Additionally ATM regulates the activity of proteins such as Chk2 which further propagates signals to p53 influencing decisions between cell cycle arrest and apoptosis. These interactions link ATM closely to essential processes like DNA repair and cell survival highlighting its role in genomic maintenance.

ATM mutations or dysregulation leads to Ataxia Telangiectasia an autosomal recessive disorder characterized by neurodegeneration immune deficiencies and cancer predisposition. ATM dysfunction also connects to cancer development particularly breast cancer where it transmits signals involving BRCA1 contributing to DNA repair through homologous recombination. Understanding ATM dynamics and related pathways has important implications for developing therapeutic strategies to manage or mitigate effects associated with its dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed : 10550055, PubMed : 10839545, PubMed : 10910365, PubMed : 12556884, PubMed : 14871926, PubMed : 15064416, PubMed : 15448695, PubMed : 15456891, PubMed : 15790808, PubMed : 15916964, PubMed : 17923702, PubMed : 21757780, PubMed : 24534091, PubMed : 35076389, PubMed : 9733514). Recognizes the substrate consensus sequence [ST]-Q (PubMed : 10550055, PubMed : 10839545, PubMed : 10910365, PubMed : 12556884, PubMed : 14871926, PubMed : 15448695, PubMed : 15456891, PubMed : 15916964, PubMed : 17923702, PubMed : 24534091, PubMed : 9733514). Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism (By similarity). Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FBXW7, FANCD2, NFKBIA, BRCA1, CREBBP/CBP, RBBP8/CTIP, MRE11, nibrin (NBN), RAD50, RAD17, PELI1, TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C (PubMed : 10550055, PubMed : 10766245, PubMed : 10802669, PubMed : 10839545, PubMed : 10910365, PubMed : 10973490, PubMed : 11375976, PubMed : 12086603, PubMed : 15456891, PubMed : 19965871, PubMed : 21757780, PubMed : 24534091, PubMed : 26240375, PubMed : 26774286, PubMed : 30612738, PubMed : 30886146, PubMed : 30952868, PubMed : 38128537, PubMed : 9733515, PubMed : 9843217). May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation (PubMed : 19965871). Phosphorylates ATF2 which stimulates its function in DNA damage response (PubMed : 15916964). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed : 29203878). Phosphorylates TTC5/STRAP at 'Ser-203' in the cytoplasm in response to DNA damage, which promotes TTC5/STRAP nuclear localization (PubMed : 15448695). Also involved in pexophagy by mediating phosphorylation of PEX5 : translocated to peroxisomes in response to reactive oxygen species (ROS), and catalyzes phosphorylation of PEX5, promoting PEX5 ubiquitination and induction of pexophagy (PubMed : 26344566).
See full target information ATM

Publications (26)

Recent publications for all applications. Explore the full list and refine your search

Aging 16:9692-9708 PubMed38843391

2024

Prognostic and therapeutic roles of in cutaneous melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jiani Xiong,Liping Zhu,Yunrong Fu,Zhoujie Ye,Cuimin Deng,Xinrui Wang,Yu Chen

Cancer & metabolism 11:20 PubMed37932830

2023

ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Cristina Terlizzi,Viviana De Rosa,Francesca Iommelli,Antonio Pezone,Giovanna G Altobelli,Maurizio Maddalena,Jelena Dimitrov,Caterina De Rosa,Carminia Maria Della Corte,Vittorio Enrico Avvedimento,Silvana Del Vecchio

Acta biochimica et biophysica Sinica 55:842-852 PubMed37227155

2023

The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Lu,Panpan Huang,Yanli Li,Wenyu Liu,Jing Li,Rui Zhao,Haihua Feng,Ce Shi,Gaolu Cao

Nature communications 14:1244 PubMed36871014

2023

Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage.

Applications

Unspecified application

Species

Unspecified reactive species

Annarita Nappi,Caterina Miro,Antonio Pezone,Alfonso Tramontano,Emery Di Cicco,Serena Sagliocchi,Annunziata Gaetana Cicatiello,Melania Murolo,Sepehr Torabinejad,Elena Abbotto,Giuseppina Caiazzo,Maddalena Raia,Mariano Stornaiuolo,Dario Antonini,Gabriella Fabbrocini,Domenico Salvatore,Vittorio Enrico Avvedimento,Monica Dentice

Aging 15:492-512 PubMed36656721

2023

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Ya Chiu,Qing Sun,Frank T Zenke,Andree Blaukat,Lyubomir T Vassilev

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36:e22495 PubMed35947121

2022

Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haoge Luo,Yanan Liu,Yang Li,Chaoke Zhang,Bingbing Yu,Chen Shao

Frontiers in nutrition 9:854655 PubMed35836584

2022

Folic Acid Preconditioning Alleviated Radiation-Induced Ovarian Dysfunction in Female Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Qianyu Zhang,Zhifu Wei,Huinan Weng,Ye Chen,Jie Zhang,Shiwei Mei,Jiahui Wei,Xiulan Zhu,Yingqi Nong,Jianxing Ruan,Wenjuan Liu,Ruiqiong Zhou,Fang Wang,Yanni Xie,Junjiu Huang,Xiqian Zhang,Fenghua Liu

Oxidative medicine and cellular longevity 2022:4201287 PubMed35783188

2022

Inhibition of PLK3 Attenuates Tubular Epithelial Cell Apoptosis after Renal Ischemia-Reperfusion Injury by Blocking the ATM/P53-Mediated DNA Damage Response.

Applications

Unspecified application

Species

Unspecified reactive species

Weiming Deng,Xiangling Wei,Zhenwei Xie,Rui Zhang,Zhanwen Dong,Jinhua Zhang,You Luo,Qingdi Cheng,Ruojiao Wang,Heng Li,Ning Na

Molecular cancer therapeutics 21:859-870 PubMed35405736

2022

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies.

Applications

Unspecified application

Species

Unspecified reactive species

Astrid Zimmermann,Frank T Zenke,Li-Ya Chiu,Heike Dahmen,Ulrich Pehl,Thomas Fuchss,Thomas Grombacher,Beatrix Blume,Lyubomir T Vassilev,Andree Blaukat

Acta biochimica et biophysica Sinica 54:37-46 PubMed35130632

2022

miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yongxiang Yin,Jinqiu Zhang,Tao Ma,Daozhen Chen,Daru Lu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com